INDIAN BIOPHARMA INDUSTRY GROWING AT 12 CROSSES ₹ 22,000 CRORE BioSpectrum Top 20 Biopharma Special  The Indian Biopharma Industry with over 300 companies is growing at 12 per cent growth against the pharma industry growth which is passing through tough situation postGST, ban on manufacture, sale and distribution of over 340 fixed dose combination FDC drugs. For the year 2018-19 the Biopharma Industry crossed Rs 22,124 crore over previous year’s revenue of Rs 18,290 core with exports comprising of Rs 14,423 crore in 2018-19 witnessing growth over last year’s exports of 13,925 crore.